Black Diamond Therapeutics (BDTX) Net Equity Issued and Repurchased (2019 - 2024)
Black Diamond Therapeutics (BDTX) posted Net Equity Issued and Repurchased of -$500000.0 for Q3 2024, down 102.38% on a QoQ basis from $21.0 million in Q2 2024, and down 100.7% year-over-year from $71.9 million in Q4 2023.
Black Diamond Therapeutics (BDTX) Net Equity Issued and Repurchased (2019 - 2024) Analysis & Trends
Black Diamond Therapeutics' Net Equity Issued and Repurchased history runs 3 years deep, the most recent figure standing at -$500000.0 for Q3 2024.
- Quarterly Net Equity Issued and Repurchased fell 100.7% year-over-year to -$500000.0 in Q3 2024, while the trailing twelve-month figure through Jun 2025 was -$500000.0 (down 100.52% YoY) and the FY2024 annual result came in at $24.5 million, down 65.91% from the prior year.
- Net Equity Issued and Repurchased was -$500000.0 for Q3 2024 at Black Diamond Therapeutics, down from $21.0 million in the prior quarter.
- Across five years, Net Equity Issued and Repurchased topped out at $71.8 million in Q3 2023 and bottomed at -$500000.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 163.10 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 141.90 Mn |
| 10 | Black Diamond Therapeutics | 99.59 Mn | -18.67 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | -500,000.00 |
| Sep 30, 2024 | -500,000.00 |
| Jun 30, 2024 | 21.01 Mn |
| Jun 30, 2024 | 21.01 Mn |
| Mar 31, 2024 | 3.98 Mn |
| Mar 31, 2024 | 3.98 Mn |
| Sep 30, 2023 | 71.85 Mn |
| Sep 30, 2023 | 71.85 Mn |
| Dec 31, 2019 | 84.83 Mn |
| Dec 31, 2019 | 84.83 Mn |